RESÚMENES JULIO 2008

.

Other Neuropsychiatric Disorders & General Information

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

5 - Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer’s Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial

David L. Sultzer, Sonia M. Davis, Pierre N. Tariot, Karen S. Dagerman, Barry D. Lebowitz, Constantine G. Lyketsos, Robert A. Rosenheck, John K. Hsiao, Jeffrey A. Lieberman, and Lon S. Schneider, CATIE-AD Study Group

Am J Psychiatry 2008; 165:844-854

3! - Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia

Paula A. Rochon, Sharon-Lise Normand, Tara Gomes, Sudeep S. Gill, Geoffrey M. Anderson, Magda Melo, Kathy Sykora, Lorraine Lipscombe, Chaim M. Bell, Jerry H. Gurwitz

Arch Intern Med. 2008;168(10):1090-1096

 

3 - Efficacy and clinical safety of ramelteon: An evidence-based review

Michael J. Sateia, Paula Kirby-Long and Jennifer L. Taylor

Sleep Medicine Reviews. Volume 12, Issue 4, August 2008, Pages 319-332

 

3! - Psychiatric Disorders in Pregnant and Postpartum Women in the United States

Oriana Vesga-López, Carlos Blanco, Katherine Keyes, Mark Olfson, Bridget F. Grant, Deborah S. Hasin

Arch Gen Psychiatry. 2008;65(7):805-815

 

3 - Delirium and its Treatment

Attard, Azizah; Ranjith, Gopinath; Taylor, David

CNS Drugs. 22(8):631-644, 2008

3 - Efficacy and Tolerability of Pharmacotherapies for Borderline Personality Disorder

Bellino, Silvio; Paradiso, Erika; Bogetto, Filippo

CNS Drugs. 22(8):671-692, 2008

3 - Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders

Carmina G Bernardo, Vivek Singh & Peter M Thompson

Expert Opinion on Drug Safety. July 2008, Vol. 7, No. 4, Pages 435-445

 

3 - Management Strategies for Premenstrual Syndrome/Premenstrual Dysphoric Disorder

Courtney I Jarvis, Ann M Lynch, Anna K Morin

The Annals of Pharmacotherapy: Vol. 42, No. 7, pp. 967-978

3! - Very Low Birth Weight and Behavioral Symptoms of Attention Deficit Hyperactivity Disorder in Young Adulthood: The Helsinki Study of Very-Low-Birth-Weight Adults

Sonja Strang-Karlsson, Katri Räikkönen, Anu-Katriina Pesonen, Eero Kajantie, E. Juulia Paavonen, Jari Lahti, Petteri Hovi, Kati Heinonen, Anna-Liisa Järvenpää, Johan G. Eriksson, and Sture Andersson

Am J Psychiatry Published July 15, 2008

3 - Interactions Between Eating Disorders and Drug Abuse

Franko, Debra L; Dorer, David J; Keel, Pamela K; Jackson, Safia; Manzo, Mary Pat; Herzog, David B

Journal of Nervous & Mental Disease. 196(7):556-561, July 2008

3! - Fracture Risk From Psychotropic Medications: A Population-Based Analysis

Bolton, James M; Metge, Colleen; Lix, Lisa; Prior, Heather; Sareen, Jitender; Leslie, William D

Journal of Clinical Psychopharmacology. 28(4):384-391, August 2008

3 - Antipsychotic Withdrawal-Induced Relapse Predicts Future Relapses in Institutionalized Adults With Severe Intellectual Disability

Janowsky, David S; Barnhill, L. Jarrett; Khalid, Abdul S; Davis, John M

Journal of Clinical Psychopharmacology. 28(4):401-405, August 2008

5< - Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers

N Antypa, A J W Van der Does, A H M Smelt, and R D Rogers

J Psychopharmacol. First published on June 26, 2008

3! - Risk of cerebrovascular events in elderly users of antipsychotics

B C Kleijer, R J van Marum, A C G Egberts, P A F Jansen, W Knol, and E R Heerdink

Journal of Psychopharmacology. First published on July 17, 2008

GRATIS 3! - Key lessons learned from short-term treatment trials of cholinesterase inhibitors for amnestic MCI

Stephen Salloway, Stephen Correia and Sharon Richardson

International Psychogeriatrics, Volume 20, Issue 01, February 2008, pp 40-46

 

GRATIS 3! - High rate of conversion to Alzheimer's disease in a cohort of amnestic MCI patients

Klaus Schmidtke and Sonja Hermeneit

International Psychogeriatrics, Volume 20, Issue 01, February 2008, pp 96-108

 

3 - The evidence is not convincing (FOR THE EFFICACY OF CHOLINESTERASE INHIBITORS IN THE SYMPTOMATIC TREATMENT OF ALZHEIMER'S DISEASE)

Hanna Kaduszkiewicz, Hendrik van den Bussche and Thomas Zimmermann

International Psychogeriatrics, Volume 20, Issue 02, April 2008, pp 260-279Bottom of Form

 

3 - Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

Sergiy Konovalov, Sunanda Muralee and Rajesh R. Tampi

International Psychogeriatrics, Volume 20, Issue 02, April 2008, pp 293-308

 

3 - The relationship between elderly suicide rates and elderly dependency ratios: a cross-national study using data from the WHO data bank

Ajit Shah, Mellisha Padayatchi and Kavita Das

International Psychogeriatrics (2008), 20:596-604

 

3! - Dose form modification – a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients

Jean Stubbs, Camilla Haw and Geoff Dickens

International Psychogeriatrics (2008), 20:616-627

 

3 - Elderly suicide rates: cross-national comparisons of trends over a 10-year period

Ajit Shah, Ravi Bhat, Sheena MacKenzie and Chris Koen

International Psychogeriatrics (2008), 20:673-686

 

3 - Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice

Hiroyuki Umegaki, Akio Itoh, Yusuke Suzuki and Toshitaka Nabeshima

International Psychogeriatrics (2008), 20:800-806

 

3 - Depressive symptoms in epilepsy : prevalence, impact, aetiology, biological correlates and effect of treatment with antiepileptic drugs.
Miller JM, Kustra RP, Vuong A, Hammer AE, Messenheimer JA

Drugs. 2008;68(11):1493-509

 

3 - Definitions of the Term 'Recovered' in Schizophrenia and Other Disorders
Ann Færden, Ragnar Nesvåg, Stephen R. Marder
Psychopathology 2008;41:271-278

 

3 - Epidemiology of Personality Disorders

Mark F. Lenzenweger

Psych Clin NA. Volume 31, Issue 3, Pages 395-403 (September 2008)

 

3 - The Frequency of Personality Disorders in Psychiatric Patients

Mark Zimmerman, Iwona Chelminski, Diane Young

Psych Clin NA. Volume 31, Issue 3, Pages 405-420 (September 2008)

 

3 - Longitudinal Course and Outcome of Personality Disorders

Andrew E. Skodol

Psych Clin NA. Volume 31, Issue 3, Pages 495-503 (September 2008)

 

3 - An 8-Week, Open-Label Trial of Duloxetine for Comorbid Major Depressive Disorder and Chronic Headache

Fernando M. Volpe

J Clin Psychiatry July 15, 2008: e1-e6

 

GRATIS 3 - Use of antipsychotics and benzodiazepines in patients with psychiatric emergencies: results of an observational trial

Stefan Wilhelm, Alexander Schacht and Thomas Wagner

BMC Psychiatry 2008, 8:61

 

3 - The use of pharmacological treatments for people with personality disorder: A systematic review of randomized controlled trials

Conor Duggan, Nick Huband, Nadja Smailagic, Michael Ferriter, Clive Adams

Personality and Mental Health. Volume 2 Issue 3, Pages 119 - 170

 

3 - Education plays a different role in Frontotemporal Dementia and Alzheimer's disease

Barbara Borroni, Antonella Alberici, Chiara Agosti, Enrico Premi, Alessandro Padovani

International Journal of Geriatric Psychiatry. Volume 23 Issue 8, Pages 796 - 800

 

3! - Motor changes during sertraline treatment in depressed patients with Parkinson's disease

J. Kulisevsky, J. Pagonabarraga, B. Pascual-Sedano, A. Gironell, C. García-Sánchez and M. Martínez-Corral

European Journal of Neurology. Published Online: 14 Jul 2008

 

3! - Completed Versus Attempted Suicide in Psychiatric Patients: a Psychological Autopsy Study

INNAMORATI, MARCO; POMPILI, MAURIZIO; MASOTTI, VITTORIA; PEARSONEI, FEDERICO; LESTER, DAVID; TATARELLI, ROBERTO; GIRARDI, PAOLO; AMORE, MARIO

Journal of Psychiatric Practice. 14(4):216-224, July 2008

3 - A systematic review of off-label uses of memantine for psychiatric disorders

Kristina Zdanys and Rajesh R. Tampi

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 6, 1 August 2008, Pages 1362-1374

 

5< - The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study

Chih-Chiang Chiu, Kuan-Pin Su, Tsung-Chi Cheng, Hsing-Cheng Liu, Ching-Jui Chang, Michael E. Dewey, Robert Stewart and Shih-Yi Huang

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 6, 1 August 2008, Pages 1538-1544

 

5< - A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder

Paolo Leombruni, Andrea Pierò, Luca Lavagnino, Annalisa Brustolin, Stefania Campisi and Secondo Fassino

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 32, Issue 6, 1 August 2008, Pages 1599-1605

 

3! - Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Narcissistic Personality Disorder: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions

Frederick S. Stinson, Deborah A. Dawson, Risë B. Goldstein, S. Patricia Chou, Boji Huang, Sharon M. Smith, W. June Ruan, Attila J. Pulay, Tulshi D. Saha, Roger P. Pickering, and Bridget F. Grant

J Clin Psychiatry 2008;69:1033-1045

 

3! - Thyroid Function and the Risk of Alzheimer Disease. The Framingham Study

Zaldy S. Tan, Alexa Beiser, Ramachandran S. Vasan, Rhoda Au, Sanford Auerbach, Douglas P. Kiel, Philip A. Wolf, Sudha Seshadri

Arch Intern Med. 2008;168(14):1514-1520

 

3! - Prevalence of dementia after age 90. Results from The 90+ Study

M. M. Corrada, R. Brookmeyer, D. Berlau, A. Paganini-Hill, and C. H. Kawas

NEUROLOGY 2008;71:337-343

3! - Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

C. Cramer, M. N. Haan, S. Galea, K. M. Langa, and J. D. Kalbfleisch

NEUROLOGY 2008;71:344-350

3 - Effect of risperidone on serum lipids and cerebrovascular mortality among elderly dementia patients with associated behavioral disturbances

María Teresa Amboage-Paz; José Antonio Díaz-Peromingo

International Journal of Psychiatry in Clinical Practice, Volume 12, Issue 3 2008, pages 196 - 201

 

3! - Neuroaetiology of chronic fatigue syndrome: An overview

Patricia Sanders; Jakob Korf

World Journal of Biological Psychiatry, Volume 9, Issue 3 2008, pages 165 - 171

 

5! - Do CSF total tau, phosphorylated tau, and β-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature

Breno S. O. Diniz;  Jony A. Pinto Jr; Orestes Vicente Forlenza

World Journal of Biological Psychiatry, Volume 9, Issue 3 2008, pages 172 - 182

 

3 - Pathophysiology and Treatment of Psychosis in Parkinson's Disease: A Review

Zahodne, Laura B; Fernandez, Hubert H

Drugs & Aging. 25(8):665-682, 2008

GRATIS 3 - New Insights into the Placebo and Nocebo Responses

Paul Enck, Fabrizio Benedetti and Manfred Schedlowski

Neuron. Volume 59, Issue 2, 31 July 2008, Pages 195-206

 

3 - Mechanisms of α7-nicotinic receptor up-regulation and sensitization to donepezil induced by chronic donepezil treatment

Yuki Takada-Takatori, Toshiaki Kume, Yuta Ohgi, Takeshi Fujii, Tetsuhiro Niidome, Hachiro Sugimoto and Akinori Akaike

European Journal of Pharmacology. Volume 590, Issues 1-3, 20 August 2008, Pages 150-156

 

GRATIS - Ambien® (zolpidem tartrate) tablets

HIGHLIGHTS OF PRESCRIBING INFORMATION

NDA 19908 S027 FDA approved labeling 4.23.08

 

GRATIS - Valium® (diazepam) tablets

HIGHLIGHTS OF PRESCRIBING INFORMATION

FDA approved labeling January 08

 

GRATIS 3 - Agitation in Older Adults

Helen H. Kyomen, Theodore H. Whitfield

Psychiatric Times. 2008; Vol. 25 No. 8

 

GRATIS 3 - La despersonalización: aspectos clínicos y neurobiológicos

 

Mauricio Sierra-Siegert

Rev Col Psiquiatria. Volumen 37 Nº 1 Marzo 2008

.

Regresar a RESÚMENES JULIO 2008

.

© 1999-2008 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.